The Fertility Center of Oregon offers onsite Diagnostic and Imaging studies for both Infertility and Gynecological treatments.
Hours of Operation:
- Monday-Friday 7:00 a.m.-5:00 p.m.
- Saturday-Sunday 7:00 a.m.-10:30 a.m.
Click on the buttons below for a drop down list of information.
Women’s Care and The Fertility Center offer laboratory services conveniently located on site. Blood work and cultures are available for General Health, Hormone monitoring, STD workups and diagnostic testing.
Follicular Stimulating Hormone (FSH)
Measurement of FSH yields information about ovarian reserve, which is the number and health of eggs in the ovaries.
Luteinizing Hormone (LH)
LH is necessary for proper development of the egg in the follicle and is secreted in large amounts immediately before ovulation.
Antimullerian Hormone (AMH)
Follicles (stored eggs) produce AMH. When the level is very low, the ovaries contain few available eggs. The menopausal transition has begun.
Chlamydia Antibody Test
Prior infection with Chlamydia can result in blockage of the fallopian tubes. Once infected, antibodies are present in the blood even if the infection has cleared. A blood test can determine if a woman has ever had Chlamydia. If positive, a radiological examination to assess tubal patency may be indicated.
Thyroid Function Tests (TFTs)
TFTs are obtained to ensure that a person’s thyroid balance is normal. Individuals with too much or too little thyroid hormone are at risk of infertility.
Blood type and Rh status are important during pregnancy. This test, if not already done, is performed before conception.
Rubella or German measles is a readily communicable virus. If contracted during pregnancy, it can result in severe impairment of the baby’s central nervous system resulting in blindness, hearing defects, cardiovascular defects. Most adults are immune to Rubella through immunization with the MMR vaccine; however, not all people develop lifelong immunity. Assessing Rubella status before pregnancy and immunizing women who do not have protective antibodies is recommended.
A type of estrogen produced by the follicles which then circulates in the blood. Estradiol is used to monitor follicular production.
The hormone produced by the corpus luteum after ovulation that supports the development and maintenance of the uterine lining.
FCO’s Andrology Laboratory is available for the evaluation of male fertility potential. The Andrology Laboratory performs routine semen analysis (sperm counts) and other andrology (sperm) tests Monday through Friday 7:00 a.m. to 1:00 p.m. and Saturday 7:00 a.m. to 10:00 a.m. by appointment only.
The microscopic evaluation of semen, which is produced by masturbation is generally the initial testing for men. Parameters such as semen volume, sperm concentration, and percentage of motile sperm, the rapidity of forward motion and the microscopic appearance of individual sperm predict the functionality of sperm.
Intrauterine insemination (IUI)
A type of artificial insemination — is a procedure for treating infertility. Washed and concentrated sperm are placed directly in the uterus around the time the ovary releases one or more eggs to be fertilized.
In many situations, the need to preserve sperm or tissue for future use is indicated. During cancer treatment, off location or difficulties with the collection are all reasons to store sperm. FCO Andrology Laboratory offers processing and annual storage for our patients to utilize.
The Center’s Embryology Laboratory aides in the development of an embryo from the stage of ovum fertilization through to the fetal stage. Full IVF laboratory for embryo retrieval and transfer.
PGT-M is a technique that assists couples, with a known inherited condition in their family, to avoid passing it on to their children. PGT-M used when one or both parents have a known genetic abnormality, and diagnostic testing is performed to determine if the embryo has also inherited the abnormality.
Preimplantation Genetic Testing for Aneuploidies (PGT-A)
PGT-A allows individuals and couples to achieve a healthy baby with additional information that may reduce the likelihood of miscarriage and decrease the risk of abnormal pregnancy.
Intracytoplasmic Sperm Injection (ICSI)
ICSI is a micromanipulation technique used in conjunction with in vitro fertilization (IVF) for the treatment of male infertility. ICSI allows a single sperm to be injected directly into the cytoplasm (inside) of an egg. For men with severe “male factor” sperm problems, this procedure has revolutionized the treatment of infertility.
Day 3 Transvaginal US (PUS)
Early in the menstrual cycle, all the eggs which reside in follicles can be observed. This measurement of the “antral follicle count” in conjunction with laboratory studies is helpful to determine ovarian reserve.
Insertion of a small catheter through the cervix into the endometrial cavity is necessary for the SHG. Once the catheter is in place, sterile saline is injected while observing the cavity by transvaginal ultrasonography. The test can detect conditions in the uterus, which would impair implantation or increase the risk of miscarriage.
The HSG is an x-ray procedure which demonstrates the shape, size and contour of the endometrial cavity. If the fallopian tubes are patent, contrast passes into the tubes and will be observed spilling into the peritoneal cavity. The test is scheduled following completion of menstruation but before ovulation.
Urine Luteinizing Hormone Test (uLH)
Screening urine daily for the secretion of uLH is useful for the timing of intercourse or of insemination. This hormone is detected in the urine 24 to 36 hours before ovulation. Kits available from the pharmacy are utilized for detection.